SION Earnings Date: Nov 4, 2026 (Estimated) — Sionna Therapeutics, Inc.
NASDAQ · Healthcare · Biotechnology
Updated
When is SION's next earnings date?
Sionna Therapeutics, Inc. (SION) is expected to report Q3 2026 earnings on Wednesday, November 4, 2026 at 7:00 AM ET (before market open); the date is an estimate and has not been confirmed by the company. The consensus estimate is EPS of -$0.64.
How did SION do in its last earnings report?
In its most recent report on Aug 6, 2026 (Q2 2026), Sionna Therapeutics, Inc. posted EPS of -$0.66 versus the -$0.65 estimate, a miss of 3.1%. Revenue was $0. The stock's 1-day post-earnings move was +4.8%.
How much does SION stock move after earnings?
SION beat EPS estimates in 3 of its last 5 reported quarters. Over the last 6 reports the stock moved an average of 6.3% (up or down) in the day after earnings.
About Sionna Therapeutics, Inc.
Sionna Therapeutics, Inc., a clinical-stage biopharmaceutical company, researches and develops medicines for the treatment of cystic fibrosis (CF). It develops galicaftor (SION-2222), a transmembrane domain 1 (TMD1)-directed cystic fibrosis transmembrane conductance regulator (CFTR) that has completed Phase 2 trial; navocaftor (SION-3067), a potentiator that has completed Phase 2 trial; SION-109, an intracellular loop 4 directed CFTR corrector that has completed Phase 1 trial; SION-2851, a TMD1-directed CFTR corrector that has completed Phase 1 trial; SION-451, which is nucleotide-binding domain 1 stabilizer in Phase 1 trial; and SION-719, which is nucleotide-binding domain 1 stabilizer in Phase 2a proof-of-concept trial. The company was formerly known as Sling Therapeutics, Inc. and changed its name to Sionna Therapeutics, Inc. in July 2021. Sionna Therapeutics, Inc. was incorporated in 2019 and is headquartered in Waltham, Massachusetts.
Earnings History
| Date | Period | EPS Est. | EPS Act. | Surprise | Revenue | Result | 1D Δ | 1W Δ | 1M Δ |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-06 | Q2 2026 | -0.65 | -0.66 | -3.12% | $0 | ❌ Miss | +4.80% | -86.80% | -85.74% |
| 2026-05-12 | Q1 2026 | -0.51 | -0.60 | -17.65% | $0 | ❌ Miss | -10.90% | -14.60% | -25.94% |
| 2026-03-02 | Q4 2025 | -0.56 | -0.46 | +17.86% | $0 | ✅ Beat | -7.17% | -1.67% | +0.33% |
| 2025-11-05 | Q3 2025 | -0.49 | -0.46 | +6.12% | $0 | ✅ Beat | -1.57% | +2.30% | +14.70% |
| 2025-08-11 | Q2 2025 | -0.55 | -0.41 | +25.45% | $0 | ✅ Beat | +13.36% | +17.83% | +38.65% |
| 2025-03-20 | Q4 2024 | — | -3.38 | — | $0 | — | +0.00% | -13.26% | -20.25% |
Showing last 6 quarters.